IRIX— IRIDEX CORP

Health CareElectromedical & Electrotherapeutic Apparatus$15M mkt cap

Metric	FY2026	FY2024	FY2023	FY2022
Total revenues	$52.7M+8.2%	$48.7M-6.2%	$51.9M-9.0%	$57.0M
Cost of revenues	$33.4M+14.7%	$29.2M-3.0%	$30.1M-4.9%	$31.6M
Gross profit	$19.2M-1.4%	$19.5M-10.6%	$21.8M-14.0%	$25.4M
Research and development	$3.7M-32.7%	$5.4M-20.2%	$6.8M-4.8%	$7.2M
Sales and marketing	$10.4M-17.4%	$12.6M-22.5%	$16.2M-10.7%	$18.2M
General and administrative	$7.7M-20.9%	$9.8M+11.8%	$8.7M+15.8%	$7.6M
Total operating expenses	$21.8M-21.6%	$27.8M-12.6%	$31.8M-3.3%	$32.9M
Loss from operations	-$2.6M+69.0%	-$8.3M+17.0%	-$10.0M-32.7%	-$7.5M
Other expense, net	-$1.8M-235.0%	-$540K-202.5%	$527K+778.3%	$60K
Loss from operations before provision for income taxes	-$4.4M+50.5%	-$8.8M+6.7%	-$9.5M-26.7%	-$7.5M
Provision for income taxes	$57K-16.2%	$68K-24.4%	$90K+38.5%	$65K
Net loss	-$4.4M+50.2%	-$8.9M+6.9%	-$9.6M-26.8%	-$7.5M
Basic	$16.9M+3.0%	$16.4M+1.9%	$16.1M+1.2%	$15.9M
Diluted	$16.9M+3.0%	$16.4M+1.9%	$16.1M+1.2%	$15.9M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 16 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.